Venrock Healthcare Capital Partners III, L.P. bought $929K of KalVista Pharmaceuticals (KALV)

Executed Feb 7 2025, disclosed Feb 11 2025, 4 days later.

Value, as filed

$929K

100,352 sh across 2 lots

Executed

Feb 7 2025

the trade date, as filed

Disclosed

Feb 11 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer

VP Venrock Healthcare Capital Partners III, L.P. 10% owner profile →

Venrock Healthcare Capital Partners III, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in KALV. The largest single filing was $929K of KALV (100,352 sh across 2 lots, as filed), executed Feb 7 2025. The median gap between execution and disclosure was 4 days.

The name

KALV KALV KALV · 19 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→